IRIS
CHIMENTI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.246
AS - Asia 6.507
EU - Europa 5.850
Continente sconosciuto - Info sul continente non disponibili 818
SA - Sud America 800
AF - Africa 154
OC - Oceania 53
Totale 62.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 47.956
SG - Singapore 2.659
CN - Cina 1.633
DE - Germania 839
UA - Ucraina 780
IT - Italia 768
RU - Federazione Russa 717
BR - Brasile 681
HK - Hong Kong 529
FR - Francia 482
IE - Irlanda 479
VN - Vietnam 473
SE - Svezia 457
GB - Regno Unito 405
FI - Finlandia 272
BD - Bangladesh 199
PL - Polonia 196
CA - Canada 195
KR - Corea 185
IN - India 160
JP - Giappone 153
TR - Turchia 80
NL - Olanda 77
ES - Italia 70
PK - Pakistan 60
ID - Indonesia 57
BE - Belgio 52
AR - Argentina 49
AU - Australia 48
EG - Egitto 44
MX - Messico 43
CH - Svizzera 42
ZA - Sudafrica 35
IQ - Iraq 32
RO - Romania 30
IR - Iran 29
TW - Taiwan 29
UZ - Uzbekistan 28
PH - Filippine 27
AT - Austria 23
KG - Kirghizistan 23
MY - Malesia 22
GR - Grecia 20
EU - Europa 19
IL - Israele 19
EC - Ecuador 18
AE - Emirati Arabi Uniti 17
HU - Ungheria 17
LT - Lituania 17
CZ - Repubblica Ceca 16
MA - Marocco 16
PT - Portogallo 16
SK - Slovacchia (Repubblica Slovacca) 16
JM - Giamaica 15
TH - Thailandia 15
CL - Cile 14
CO - Colombia 12
DK - Danimarca 12
NG - Nigeria 12
OM - Oman 11
EE - Estonia 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
DZ - Algeria 9
JO - Giordania 9
NP - Nepal 9
PY - Paraguay 9
RS - Serbia 9
TN - Tunisia 9
HR - Croazia 8
PE - Perù 8
CR - Costa Rica 7
ET - Etiopia 7
LB - Libano 6
LV - Lettonia 6
VE - Venezuela 6
CY - Cipro 5
NO - Norvegia 5
AZ - Azerbaigian 4
BJ - Benin 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KE - Kenya 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
GH - Ghana 3
HN - Honduras 3
KW - Kuwait 3
MD - Moldavia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
GA - Gabon 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A1 - Anonimo 1
Totale 61.608
Salva come PNG Salva come JPEG
Città #
Woodbridge 13.772
Wilmington 10.832
Houston 9.452
Fairfield 1.589
Singapore 1.323
Ann Arbor 1.272
Ashburn 1.067
Chandler 1.064
Jacksonville 687
Seattle 673
San Jose 633
Beijing 568
Cambridge 562
Hong Kong 494
Dublin 476
Medford 385
New York 329
Council Bluffs 294
Dearborn 290
Zhengzhou 264
The Dalles 241
Santa Clara 234
Los Angeles 192
Lawrence 181
Rome 151
Dallas 149
Kraków 137
Hanoi 134
Tokyo 123
Ho Chi Minh City 116
Helsinki 103
Buffalo 102
Moscow 102
San Diego 98
Lauterbourg 89
Mülheim 87
Shanghai 87
Menlo Park 85
Munich 83
Boardman 77
São Paulo 72
Redwood City 62
Milan 58
London 49
Phoenix 48
Chicago 46
Toronto 45
Redondo Beach 42
Stockholm 41
Brooklyn 40
Warsaw 40
Hefei 39
Nanjing 39
San Mateo 39
Guangzhou 38
Montreal 38
Orem 37
Bar Harbor 36
Norwalk 33
Brussels 29
Denver 29
Jakarta 29
Frankfurt am Main 28
Jönköping 28
University Park 28
Ankara 27
Atlanta 27
Verona 27
Columbus 26
Naples 25
Turin 25
Falls Church 24
Madrid 24
Nuremberg 24
San Francisco 24
Detroit 22
Hangzhou 22
Chennai 21
Kunming 21
Philadelphia 21
Boston 20
Da Nang 20
Haiphong 20
Mountain View 20
Palo Alto 20
Nanchang 19
Belo Horizonte 18
Dong Ket 18
Manchester 18
Auburn Hills 17
Johannesburg 17
Poplar 17
Curitiba 16
Florence 15
Lahore 15
Paris 15
Rio de Janeiro 15
Duncan 14
Hamilton 14
Mexico City 14
Totale 50.312
Salva come PNG Salva come JPEG
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.668
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.237
Quality of life in patients with plaque psoriasis treated with biologic therapies 822
Atopic dermatitis and dental manifestations 547
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 543
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 543
Topical lactoferrin can improve stable psoriatic plaque 512
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 511
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 508
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 505
Clinical aspects of the oral cavity in patients with psoriasis: an initial study and a proposal of a new evaluation method 504
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 503
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 498
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 493
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 492
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes 491
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 489
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 489
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 488
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 480
Apremilast for the treatment of psoriasis. 480
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 479
Tazarotene as alternative topical treatment for onychomycosis 475
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 472
Actinic keratosis treated with an immune response modifier: a case report of six patients 466
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 466
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 463
Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2] 461
New topical treatments for psoriasis 461
Treatment of trachyonychia with tazarotene 458
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 457
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 451
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 451
Lung nodule and facial erythematous plaques: a quiz 446
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 444
Stress reactivity in psoriatic patients 442
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 442
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 442
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 441
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 440
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 439
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 439
Phrynoderma: a cutaneous sign of an inadequate diet 439
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 438
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice 437
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 436
The significance of the development of antinuclear antibodies during infliximab treatment 435
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 434
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 433
Reply to Scalone and Cortesi: ‘‘Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs’’ 433
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 431
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome 430
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 429
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 429
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 429
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 427
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 426
Treatment of lentigo maligna with tazarotene 0.1% gel 424
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 424
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 424
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21 422
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus 422
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study 422
Severe acne successfully treated with etanercept 421
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 421
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 420
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 419
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 418
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 415
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 413
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 411
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 409
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 408
Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy 405
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 405
Erysipeloid cutaneous metastasis from bladder carcinoma 405
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 405
Tofacitinib for the treatment of psoriasis 404
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 402
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 402
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 401
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 399
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 396
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 393
Pyoderma vegetans and ulcerative colitis 390
Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene J Invest Dermatol. 2007 Sep;127(9):2271-3. 388
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 388
Analysis of risk factors in cutaneous malignant melanoma: an italian population-based study 387
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 386
Zosteriform metastasis of occult bronchogenic carcinoma 385
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 383
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 382
Immunologic biomarkers for clinical and therapeutic management of psoriasis 381
HIV-associated primary cutaneous anaplastic large cell lymphoma: A clinicopathological subset with more aggressive behavior? Case report and review of the literature 381
Ichthyosiform mycosis fungoides: A neoplastic acquired ichthyosis [5] 378
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 375
Metastatic Crohn's disease of the forehead 374
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 373
Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A 372
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience 372
Totale 46.029
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.054 0 272 151 138 59 177 102 113 146 184 141 571
2022/20232.770 258 230 141 407 234 582 181 155 286 27 168 101
2023/20241.153 119 52 81 50 104 290 81 106 23 38 25 184
2024/20254.209 176 802 431 261 112 240 380 210 348 327 476 446
2025/20267.045 560 328 807 602 566 230 843 676 734 643 777 279
2026/2027722 399 323 0 0 0 0 0 0 0 0 0 0
Totale 62.428